China Universal Asset Management Co., Ltd. Arcutis Biotherapeutics, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.05 Billion
- Q1 2025
A detailed history of China Universal Asset Management Co., Ltd. transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 23,797 shares of ARQT stock, worth $356,003. This represents 0.04% of its overall portfolio holdings.
Number of Shares
23,797
Previous 24,818
4.11%
Holding current value
$356,003
Previous $345,000
7.83%
% of portfolio
0.04%
Previous 0.03%
Shares
16 transactions
Others Institutions Holding ARQT
# of Institutions
250Shares Held
126MCall Options Held
605KPut Options Held
170K-
Suvretta Capital Management, LLC New York, NY11.4MShares$171 Million7.82% of portfolio
-
Jennison Associates LLC11.4MShares$170 Million0.13% of portfolio
-
Rubric Capital Management LP New York, NY11MShares$164 Million4.91% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA8.79MShares$131 Million8.65% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$129 Million0.0% of portfolio
About Arcutis Biotherapeutics, Inc.
- Ticker ARQT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,187,500
- Market Cap $900M
- Description
- Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...